Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
Go back to Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022| (NASDAQ: SPRB) | Delayed: 43.99 -1.16 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.15 | 52 Week High | $ | |||
| Open | $45.47 | 52 Week Low | $ | |||
| Day High | $45.47 | P/E | N/A | |||
| Day Low | $43.62 | EPS | $ | |||
| Volume | 66,482 | |||||



